MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10096-024-04885-w

Медицинская библиотека · European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024

Seven-day antibiotic therapy for Enterobacterales bacteremia in high-risk neutropenic patients: toward a new paradigm.

Herrera Fabián, Torres Diego, Laborde Ana, Jordán Rosana, Tula Lucas, Mañez Noelia, Pereyra María Laura, Suchowiercha Nadia, Berruezo Lorena, Gudiol Carlota, Ibáñez María Luz González, Eusebio María José, Lambert Sandra, Barcán Laura, Rossi Inés Roccia, Nicola Federico, Pennini Magdalena, Monge Renata, Blanco Miriam, Visús Mariángeles, Reynaldi Mariana, Carbone Ruth, Pasterán Fernando, Corso Alejandra, Rapoport Melina, Carena Alberto Angel, Argentine Group for the Study of Bacteremia in Cancer, Stem Cell Transplant (ROCAS) Study

СтатьяНаблюдательное исследованиеМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

PURPOSE: Data on short courses of antibiotic therapy for Enterobacterales bacteremia in high-risk neutropenic patients are limited. The aim of the study was to describe and compare the frequency of bacteremia relapse, 30-day overall and infection-related mortality, Clostridiodes difficile infection and length of hospital stay since bacteremia among those who received antibiotic therapy for 7 or 14 days.

METHODS

This is a multicenter, prospective, observational cohort study in adult high-risk neutropenic patients with hematologic malignancies or hematopoietic stem cell transplant and monomicrobial Enterobacterales bacteremia. They received appropriate empirical antibiotic therapy, had a clinical response within 7 days, and infection source control. Clinical, epidemiological and outcomes variables were compared based on 7 or 14 days of AT.

RESULTS

Two hundred patients were included (100, 7-day antibiotic therapy; 100, 14-day antibiotic therapy). Escherichia coli was the pathogen most frequently isolated (47.5%), followed by Klebsiella sp. (40.5%). Among those patients that received 7-day vs. 14-day antibiotic course, a clinical source of bacteremia was found in 54% vs. 57% (p = 0.66), multidrug-resistant Enterobacterales isolates in 28% vs. 30% (p = 0.75), and 40% vs. 47% (p = 0.31) received combined empirical antibiotic therapy. Overall mortality was 3% vs. 1% (p = 0.62), in no case related to infection; bacteremia relapse was 7% vs. 2% (p = 0.17), and length of hospital stay since bacteremia had a median of 9 days (IQR: 7-15) vs. 14 days (IQR: 13-22) (p =  < 0.001).

CONCLUSIONS

These data suggest that seven-day antibiotic therapy might be adequate for patients with high-risk neutropenia and Enterobacterales bacteremia, who receive appropriate empirical therapy, with clinical response and infection source control.

Для цитирования: Herrera Fabián, Torres Diego, Laborde Ana, Jordán Rosana, Tula Lucas, Mañez Noelia, Pereyra María Laura, Suchowiercha Nadia, Berruezo Lorena, Gudiol Carlota, Ibáñez María Luz González, Eusebio María José, Lambert Sandra, Barcán Laura, Rossi Inés Roccia, Nicola Federico, Pennini Magdalena, Monge Renata, Blanco Miriam, Visús Mariángeles, Reynaldi Mariana, Carbone Ruth, Pasterán Fernando, Corso Alejandra, Rapoport Melina, Carena Alberto Angel, Argentine Group for the Study of Bacteremia in Cancer, Stem Cell Transplant (ROCAS) Study. Seven-day antibiotic therapy for Enterobacterales bacteremia in high-risk neutropenic patients: toward a new paradigm.. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2024. DOI: 10.1007/s10096-024-04885-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.